2023-02-01 2024-01-31 false No description of principal activity Debitam - Tax and Accounts 1.0 13168453 bus:FullAccounts 2023-02-01 2024-01-31 13168453 bus:Micro-entities 2023-02-01 2024-01-31 13168453 bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 13168453 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 13168453 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13168453 2023-02-01 2024-01-31 13168453 2024-01-31 13168453 bus:RegisteredOffice 2023-02-01 2024-01-31 13168453 core:WithinOneYear 2024-01-31 13168453 core:AfterOneYear 2024-01-31 13168453 2022-02-01 13168453 bus:Director1 2023-02-01 2024-01-31 13168453 bus:Director1 2024-01-31 13168453 bus:Director1 2022-02-01 2023-01-31 13168453 bus:Director2 2023-02-01 2024-01-31 13168453 bus:Director2 2024-01-31 13168453 bus:Director2 2022-02-01 2023-01-31 13168453 bus:CompanySecretary1 2023-02-01 2024-01-31 13168453 bus:LeadAgentIfApplicable 2023-02-01 2024-01-31 13168453 2022-02-01 2023-01-31 13168453 2023-01-31 13168453 core:WithinOneYear 2023-01-31 13168453 core:AfterOneYear 2023-01-31 13168453 bus:EntityAccountantsOrAuditors 2022-02-01 2023-01-31 13168453 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 13168453 core:CostValuation core:Non-currentFinancialInstruments 2023-01-31 13168453 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-01-31 13168453 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-01-31 13168453 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-01-31 13168453 core:Non-currentFinancialInstruments 2024-01-31 13168453 core:Non-currentFinancialInstruments 2023-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13168453
England and Wales

 

 

 


Report of the Directors and Unaudited Financial Statements

for the year ended 31 January 2024

for

VX PHARMA (U.K.) LTD

 
 
 
£
2024
£
   
£
2023
£
Called up share capital not paid 200  200 
Current assets 1,347  1,422 
Creditors: amount falling due within one year (8,395) (7,627)
Net current assets (7,048) (6,205)
Total assets less current liabilities (6,848) (6,005)
Creditors: amount falling due after more than one year (22,635) (22,635)
Net assets (29,483) (28,640)
 
Capital and reserves (29,483) (28,640)
 
  1. For the year ended 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the companies act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Donald Anthony Ewer
Director

Date approved: 09 September 2024
1
Statutory Information
VX PHARMA (U.K.) LTD is a private limited company, limited by shares, domiciled in England and Wales, registration number 13168453, registration address 23 Upland Park Road, Oxford, England, OX2 7RU, United Kingdom.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 2  (2023: 2).
2